Redefining Liver Fibrosis Risk Assessment in Indians with Type 2 Diabetes: New FIB-4 Score Cutoff for Optimizing Sequential Assessment with Transient Elastography

Redefining Liver Fibrosis Risk Assessment in Indians with Type 2 Diabetes: New FIB-4 Score Cutoff for Optimizing Sequential Assessment with Transient Elastography

Introduction: Liver fibrosis in metabolic dysfunction-associated steatotic liver disease (MASLD) is strongly related to hepatic and extrahepatic outcomes. Clinically Significant Liver Fibrosis (CSLF) screening using FIB-4 score is mandated in all T2D patients. The existing FIB-4 cutoff of 1.3 is der...

Full description

Saved in:

Bibliographic Details
Main Authors:	Rajat Deb, Soumik Goswami, Nilanjan Sengupta, Arjun Baidya, Vibhu R. Khare, Joydip Datta, Mousumi Das, Debes Ray
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2025-03-01
Series:	Indian Journal of Endocrinology and Metabolism
Subjects:	clinically significant liver fibrosis fib4 score masld transient elastography type 2 diabetes mellitus
Online Access:	https://journals.lww.com/10.4103/ijem.ijem_457_24
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Useful Biomarkers for Preeclampsia: Evaluating the Diagnostic Potential of FIB-4 and FIB-5 Indices
by: Mehmet Albayrak, et al.
Published: (2025-03-01)

Association of liver related biomarkers with incident cardiovascular disease and all-cause mortality in the Hispanic community health study/study of Latinos (HCHS/SOL), a population-based cohort study
by: Mario Jesus Trejo, et al.
Published: (2025-07-01)

FIB-4 and APRI scores for predicting severe fibrosis in chronic hepatitis C - a developing country's perspective in DAA era
by: Uros Karic, et al.
Published: (2018-03-01)

Can the 128-Hz tuning fork be an alternative to the biothesiometer for diabetic peripheral neuropathy screening? A cross-sectional study in a tertiary hospital in East India
by: Soumik Goswami, et al.
Published: (2024-06-01)

Electrohydrodynamic redox printing vs magnetron sputtering: Enhancing hardness of nanoporous silver with twinning and structural order
by: Nikolaus Porenta, et al.
Published: (2025-05-01)

Association between FIB-4 index and lower extremity arterial disease in MASLD patients: a cross-sectional study
by: Chunxia Zhang, et al.
Published: (2025-03-01)

Association between arterial stiffness and MASLD in US young adults: base on NHANES 2005-2018
by: Qing-zhong Li, et al.
Published: (2025-06-01)

Relationship between anthropometric measures and the risk of incident Metabolic dysfunction-associated steatotic liver disease: a longitudinal study
by: Takahiro Ichikawa, et al.
Published: (2025-03-01)

Glycemic variability in type 2 diabetic patients with metabolic dysfunction-associated steatotic liver disease: a case-control study
by: Yueqiu Wang, et al.
Published: (2025-12-01)

Outcomes of coronary revascularization in patients with metabolic dysfunction-associated steatotic liver disease: a systematic review
by: Jacob J. Gries, et al.
Published: (2025-08-01)

Mini-review: Serum immunoglobulins and MASLD
by: Ke-qian Chen, et al.
Published: (2025-08-01)

Editorial: Nutriomic analysis of food and functional compounds for MAFLD prevention
by: Fermin I. Milagro, et al.
Published: (2025-08-01)

Association between Triglyceride-Glucose index and onset of type 2 diabetes in metabolic Dysfunction-Associated steatotic liver disease population
by: Tengchao Zhou, et al.
Published: (2025-05-01)

Decoding survival in MASLD: the dominant role of metabolic factors
by: Zhiqiang Jin, et al.
Published: (2025-06-01)

AISI and MASLD: a nonlinear association in U.S. adults (NHANES 2017-2020)
by: Xue Xiao, et al.
Published: (2025-08-01)

Association between urinary albumin-to-creatinine ratio and all-cause and cardiovascular-cause mortality among MASLD: NHANES 2001–2018
by: Zhengjin Wang, et al.
Published: (2025-05-01)

Allantoin Serves as a Novel Risk Factor for the Progression of MASLD
by: Weiqiang Lv, et al.
Published: (2025-04-01)

A prospective study on the role of non-invasive tests in the evaluation of diabetes mellitus associated steatotic liver disease
by: Zülal İstemihan, et al.
Published: (2025-07-01)

Cardiometabolic Index as a predictor of mortality in metabolic Dysfunction-Associated Steatotic Liver Disease
by: Yang Yang, et al.
Published: (2025-07-01)

Racial and Ethnic Disparities in NAFLD: Harnessing Epigenetic and Gut Microbiota Pathways for Targeted Therapeutic Approaches
by: Mohamed Zaiou, et al.
Published: (2025-05-01)

Trends and visualization analysis of research on MASLD-Related hepatocellular carcinoma: a bibliometric analysis
by: Hongkun Yin, et al.
Published: (2025-06-01)

The emerging role of E3 ubiquitin ligases and deubiquitinases in metabolic dysfunction-associated steatotic liver disease
by: Yu Zhang, et al.
Published: (2025-03-01)

Hepatic Estrogen Receptor Alpha Overexpression Protects Against Hepatic Insulin Resistance and MASLD
by: Ester S. Alves, et al.
Published: (2025-01-01)

A Critical Role for the Mitochondrial Pyruvate Carrier in Hepatic Stellate Cell ActivationSummary
by: Mohammad Habibi, et al.
Published: (2025-01-01)

Non-invasive detection of fibrosis in non-alcoholic fatty liver disease by serum microfibrillar-associated protein 4 and its correlation with FIB-4 and transient elastography
by: Heba Abdel Rahman Eltony, et al.
Published: (2025-07-01)

Downregulation of ubiquitous microRNA-320 in hepatocytes triggers RFX1-mediated FGF1 suppression to accelerate MASH progression
by: Liu Yang, et al.
Published: (2025-08-01)

Harnessing nutrition to combat MASLD: a comprehensive guide to food-based therapeutic strategies
by: Claudia Reytor-González, et al.
Published: (2025-12-01)

Intercellular adhesion molecule-1 protects against adipose tissue inflammation and insulin resistance but promotes liver disease activity in western-diet fed mice
by: Sreepradha Eswaran, et al.
Published: (2025-07-01)

Prognostic impact of systemic inflammation indicators on all-cause and CVD mortality in adults with MASLD
by: Yaqiong Wang, et al.
Published: (2025-07-01)

The association of the metabolic score for insulin resistance and metabolic dysfunction-related steatosis liver disease: a population-based observational study
by: Haoxuan Zou, et al.
Published: (2025-07-01)

Liver and Nonliver-Related Outcomes at 2 Years Are Not Influenced by the Results of the FIB-4 Test and Liver Elastography in a Real-Life Cohort of Patients with Type 2 Diabetes
by: Ivica Grgurevic, et al.
Published: (2021-01-01)

fib International Conference on Concrete Sustainability
by: Editorial, Foreword
Published: (2022-03-01)

Association between adipose insulin resistance, serum lipoprotein(a) level, and MASLD in adult patients with T2DM in China
by: Yufang Liu, et al.
Published: (2025-08-01)

Novel subtypes of metabolic associated steatotic liver disease linked to clinical outcomes: implications for precision medicine
by: Chang Hong, et al.
Published: (2025-07-01)

Contemporary burden of mortality from chronic liver disease by sex and race/ethnicity in the United States
by: Donghee Kim, et al.
Published: (2025-07-01)

Editorial: Genetics and multi-omics approach in metabolic liver disorders
by: Omar Ramos-Lopez, et al.
Published: (2025-05-01)

Metabolic dysfunction-associated steatotic liver disease and risk of four intrahepatic and extrahepatic diseases
by: Yiyuan Xiao, et al.
Published: (2025-01-01)

Editorial: Lipid metabolism in metabolic dysfunction- associated steatotic liver disease
by: Sheetalnath Rooge, et al.
Published: (2025-03-01)

Investigating hepatic fibrosis heterogeneity by three-dimensional imaging in metabolic dysfunction-associated steatotic liver disease
by: Buket Yigit, et al.
Published: (2025-07-01)

Assessment of Liver Stiffness in Pediatric Fontan Patients Using Transient Elastography
by: Becky Chen, et al.
Published: (2016-01-01)